Kimberly Clark Corp vs Quantumscape Corp — how do they compare? Kimberly Clark Corp trades at $97.59 (market cap $32.51B), while Quantumscape Corp trades at $4.58 (market cap $2.82B). The key difference: Kimberly Clark Corp is far larger — about 11.5× Quantumscape Corp's market cap, and Kimberly Clark Corp pays a 5.24% dividend while Quantumscape Corp pays none. Which is the better fit depends on your goals — on Pluang, investors hold Kimberly Clark Corp for 93 Days and Quantumscape Corp for 37 Days on average.
| KMB | QS | |
|---|---|---|
Market Cap | $32.51B | $2.82B |
Volume | 6,139,913 | 21,878,246 |
Sector | Consumer Staples | Consumer Cyclical |
52-Week High | $121.44 | $18.44 |
52-Week Low | $93.05 | $4.52 |
Typical Hold Time | 93 Days | 37 Days |
Enterprise Value | $38.07B | $2.03B |
Dividend Yield | 5.24% | — |
Signals from Pluang's Aura AI — not financial advice
Kimberly-Clark (KMB) trades at $97.74, up 1.31% with mixed technical signals showing bearish moving averages but neutral oscillators. The company maintains strong profitability with 11.79% net margins and 129.43% ROE, though Q2 2026 earnings missed expectations. Recent news highlights executive transitions and the pending Kenvue acquisition, while dividend sustainability questions emerge amid cash flow pressures. Analyst consensus remains cautious with 61% hold ratings despite a $117.25 price target suggesting 20% upside.
KMB presents a value opportunity with attractive dividend yield near 5%, but faces integration risks from the Kenvue deal and cash flow challenges. The stock's current discount to analyst targets offers potential upside if execution improves, though investors should monitor dividend coverage and acquisition integration closely given the bearish technical trend and mixed earnings performance.
QuantumScape (QS) trades at $4.58, up 1.33% on the day, as the solid-state battery developer continues to operate without revenue while advancing its pilot production line. The stock shows bearish technical signals with negative profitability metrics (ROE: -39.08%, ROA: -34.66%) and consistent operating cash flow losses. Recent earnings showed mixed results with two beats and one miss, while analyst sentiment remains cautious with 73% hold ratings.
QS faces significant execution risk with commercialization targeted for 2029, five years behind schedule. The company relies heavily on financing activities to fund operations, creating dilution risk. While the $10.35 consensus price target suggests potential upside, investors must weigh the speculative nature of pre-revenue development against competitive threats in the evolving battery market.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
With around half of sales from personal care and another third from tissue products, Kimberly-Clark sits as a leading manufacturer of tissue and hygiene realm. Its brand mix includes Huggies, Pull-Ups, Kotex, Depend, Kleenex, and Cottonelle. The firm also operates K-C Professional, which partners with businesses to provide safety and sanitary products for the workplace. Kimberly-Clark generates just over of half its sales in North America and more than 10% in Europe, with the rest primarily concentrated in Asia and Latin America.
Read more on KMB →QuantumScape Corp is engaged in the development of next-generation solid-state lithium-metal batteries for use in electric vehicles. It developed anode-less cell design, which delivers high energy density while lowering material costs and simplifying manufacturing.
Read more on QS →